[{"question": "A 22-year-old man with sickle cell disease is brought to the emergency room for acute onset facial asymmetry and severe pain. He was in school when his teacher noted a drooping of his left face. His temperature is 99.9\u00b0F (37.7\u00b0C), blood pressure is 122/89 mmHg, pulse is 110/min, respirations are 19/min, and oxygen saturation is 98% on room air. Physical exam is notable for facial asymmetry and 4/5 strength in the patient's upper and lower extremity. A CT scan of the head does not demonstrate an intracranial bleed. Which of the following is the most appropriate treatment for this patient?", "correct_answer": "Exchange transfusion", "correct_idx": 1, "options": ["A)Alteplase", "B)Exchange transfusion", "C)Heparin", "D)Warfarin"], "prompt": "A 22-year-old man with sickle cell disease is brought to the emergency room for acute onset facial asymmetry and severe pain. He was in school when his teacher noted a drooping of his left face. His temperature is 99.9\u00b0F (37.7\u00b0C), blood pressure is 122/89 mmHg, pulse is 110/min, respirations are 19/min, and oxygen saturation is 98% on room air. Physical exam is notable for facial asymmetry and 4/5 strength in the patient's upper and lower extremity. A CT scan of the head does not demonstrate an intracranial bleed. Which of the following is the most appropriate treatment for this patient?A)Alteplase\nB)Exchange transfusion\nC)Heparin\nD)Warfarin", "subject_name": null, "output0": "Alteplase is the most appropriate treatment for this patient because it is a thrombolytic agent that is used to dissolve blood clots, and it is likely that the patient has a cerebral infarction (a stroke) caused by a blood clot. The patient's symptoms of facial asymmetry and weakness in his extremities are consistent with a cerebral infarction.\n\n", "output1": "Exchange transfusion is the most appropriate treatment for this patient because it is a life-threatening condition that requires immediate attention. The patient's symptoms of facial asymmetry and weakness are consistent with a hemolytic crisis, which is a complication of sickle cell disease. Exchange transfusion is a procedure that replaces the patient's sickled red blood cells with healthy red blood cells, which can help to improve the patient's symptoms and prevent further complications.\n\n", "output2": "The most appropriate treatment for this patient with sickle cell disease and acute onset facial asymmetry is heparin. This is because heparin is a blood thinner that can help prevent further clotting and potential stroke. The patient's symptoms are consistent with a stroke or cerebral infarction, which is a common complication of sickle cell disease.\n\n", "output3": "Warfarin is the most appropriate treatment for this patient because it is used to prevent and treat blood clots, and the patient's symptoms of facial asymmetry and weakness suggest a possible stroke or other neurological condition. The patient's age and the fact that he has sickle cell disease also increase the likelihood that he may have a blood clotting disorder.\n\n"}, {"question": "Binocular visual field half outer defect (bilateral temporal hemianopia), is the most likely site of injury:", "correct_answer": "Chiasm (optic chiasm)", "correct_idx": 3, "options": ["A)The optic nerve (optic nerve)", "B)LGN (lateral geniculate body)", "C)Depending diameter (optic tract)", "D)Chiasm (optic chiasm)"], "prompt": "Binocular visual field half outer defect (bilateral temporal hemianopia), is the most likely site of injury:A)The optic nerve (optic nerve)\nB)LGN (lateral geniculate body)\nC)Depending diameter (optic tract)\nD)Chiasm (optic chiasm)", "subject_name": null, "output0": "Binocular visual field half outer defect (bilateral temporal hemianopia) is often caused by damage to the optic nerve, which is the nerve that carries visual information from the eye to the brain. The optic nerve is the most likely site of injury for this condition.\n\n", "output1": "The lateral geniculate body (LGN) is the part of the brain that receives visual information from the eyes and sends it to the visual cortex for processing. A binocular visual field half outer defect, such as bilateral temporal hemianopia, is most likely to occur due to damage to the LGN.\n\n", "output2": "Binocular visual field half outer defect (bilateral temporal hemianopia) is most likely caused by a lesion in the optic tract, which is the bundle of nerve fibers that carries visual information from one eye to the other. This type of lesion can cause a loss of vision in one side of both eyes, resulting in a \"tunnel vision\" effect.\n\n", "output3": "Bilateral temporal hemianopia is a visual field defect that is commonly associated with injury to the optic chiasm. This structure is responsible for integrating visual information from both eyes and is critical for binocular vision. Damage to the chiasm can result in a defect that affects both sides of both visual fields.\n\n"}, {"question": "Some medicine comes with a label of 'store at a cool place only'. At what temperature should these medicines be kept?", "correct_answer": "8-15 degC", "correct_idx": 0, "options": ["A)8-15 degC", "B)2-8 degC", "C)0 degC", "D)25-28 degC"], "prompt": "Some medicine comes with a label of 'store at a cool place only'. At what temperature should these medicines be kept?A)8-15 degC\nB)2-8 degC\nC)0 degC\nD)25-28 degC", "subject_name": "Social & Preventive Medicine", "output0": "The medicines that come with the label of 'store at a cool place only' should be kept at a temperature of 8-15 degrees Celsius. This temperature range is considered cool enough to prevent the degradation of the medicine, but not so cool that it would cause the medicine to freeze.\n\n", "output1": "Medicines that come with the label of 'store at a cool place only' should be kept at a temperature between 2-8 degrees Celsius. This is because the active ingredients in these medicines are sensitive to heat and moisture, and can degrade if they are exposed to higher temperatures. By storing the medicines at a cooler temperature, you can help to preserve their effectiveness and shelf life.\n\n", "output2": "Medicines that come with the label \"store at a cool place only\" should be kept at a temperature of 0 degrees Celsius. This is because many medicines are sensitive to temperature changes and can lose their potency or become less effective if they are exposed to high temperatures.\n\n", "output3": "The medicines that come with the label \"store at a cool place only\" should be kept at a temperature between 25-28 degrees Celsius. This is because the medication is not sensitive to changes in temperature and can be stored at room temperature without any adverse effects.\n\n"}, {"question": "Hormone Replacement therapy is not indicated in:", "correct_answer": "Prevention of CAD", "correct_idx": 1, "options": ["A)Hot flashes", "B)Prevention of CAD", "C)Osteoporosis", "D)Vaginal atrophy"], "prompt": "Hormone Replacement therapy is not indicated in:A)Hot flashes\nB)Prevention of CAD\nC)Osteoporosis\nD)Vaginal atrophy", "subject_name": "Gynaecology & Obstetrics", "output0": "Hormone Replacement Therapy (HRT) is not recommended for hot flashes, as there are other treatments that are more effective and have fewer risks.\n\n", "output1": "Hormone Replacement Therapy is not recommended for the prevention of Coronary Artery Disease (CAD). While hormone replacement therapy may help to alleviate some symptoms of menopause, such as hot flashes and vaginal atrophy, it is not a proven method for preventing CAD.\n\n", "output2": "Hormone Replacement Therapy is not recommended for the prevention of osteoporosis. While it can help to reduce the risk of fractures in postmenopausal women, it can also increase the risk of other health problems, such as breast cancer and blood clots. Other treatments, such as exercise, calcium, and vitamin D, are more effective and safer for preventing osteoporosis.\n\n", "output3": "Hormone Replacement Therapy (HRT) is not recommended for the treatment of vaginal atrophy. HRT may actually increase the risk of certain types of cancer, such as endometrial cancer, and may not be effective in preventing vaginal atrophy. Other treatments, such as non-hormonal vaginal moisturizers and lubricants, may be more effective and safer for this condition.\n\n"}, {"question": "75. \u2f00 bit 46 year old man, was causing chest \u2f8e chest with shock attack, chest tube drainage after a 700 ml \u2f8e solution \u2f8e pressure of 118/82 mmHg, Center Weighted jump at 90 / min, and after a bit \u2f8e pressure decreased to 84 / 62 mmHg, Center Weighted jump at 126 / min, following the disposal of whichever top priority?\n", "correct_answer": "Face to reassess disease", "correct_idx": 3, "options": ["A)Intubated immediately", "B)Emergency thoracotomy", "C)Immediately lose \u2f8e", "D)Face to reassess disease"], "prompt": "75. \u2f00 bit 46 year old man, was causing chest \u2f8e chest with shock attack, chest tube drainage after a 700 ml \u2f8e solution \u2f8e pressure of 118/82 mmHg, Center Weighted jump at 90 / min, and after a bit \u2f8e pressure decreased to 84 / 62 mmHg, Center Weighted jump at 126 / min, following the disposal of whichever top priority?\nA)Intubated immediately\nB)Emergency thoracotomy\nC)Immediately lose \u2f8e\nD)Face to reassess disease", "subject_name": null, "output0": "Because the patient is experiencing a life-threatening situation, and intubation is the top priority to ensure proper oxygenation and ventilation.\n\n", "output1": "Based on the information provided, the patient is a 46-year-old man who is experiencing a shock attack with a chest tube drainage of 700 ml and a pressure of 118/82 mmHg. The patient's center weighted jump is 90/min, which is a sign of severe hemodynamic instability. The priority in this case is to perform an emergency thoracotomy to address the underlying cause of the patient's hemodynamic instability.\n\n", "output2": "The patient's vital signs are stable, and the immediate priority is to reduce the volume of the \u2f8e solution in the chest. This will help to decrease the pressure and prevent further damage to the lung tissue.\n\n", "output3": "Given the patient's age and the fact that he was experiencing a shock attack, it is important to first assess the patient's airway, breathing, and circulation (ABCs) and prioritize any necessary interventions. In this case, the patient's vital signs are normal, and there is no indication for immediate intubation or emergency thoracotomy. Therefore, the best course of action would be to reassess the patient's disease and determine if there are any other underlying causes for his symptoms.\n\n"}, {"question": "A 15-year-old boy is brought to the physician for evaluation of a learning disability. His teachers have reported hyperactivity during class, difficulties with social interaction, and poor scores on reading and writing assessments. Molecular analysis shows an increased number of CGG trinucleotide repeats. Which of the following findings are most likely to be seen on physical examination of this patient?", "correct_answer": "Long face and large everted ears", "correct_idx": 1, "options": ["A)Frontal balding and cataracts", "B)Long face and large everted ears", "C)Almond-shaped eyes and downturned mouth", "D)Thin upper lip and receding chin"], "prompt": "A 15-year-old boy is brought to the physician for evaluation of a learning disability. His teachers have reported hyperactivity during class, difficulties with social interaction, and poor scores on reading and writing assessments. Molecular analysis shows an increased number of CGG trinucleotide repeats. Which of the following findings are most likely to be seen on physical examination of this patient?A)Frontal balding and cataracts\nB)Long face and large everted ears\nC)Almond-shaped eyes and downturned mouth\nD)Thin upper lip and receding chin", "subject_name": null, "output0": "The patient's symptoms of hyperactivity, poor academic performance, and social interaction difficulties are consistent with a diagnosis of Fragile X syndrome, which is caused by an expansion of CGG trinucleotide repeats. One of the physical characteristics of Fragile X syndrome is frontal balding, which is often seen in individuals with this condition.\n\n", "output1": "The patient's physical examination findings are most likely to include long face and large everted ears, which are common features of individuals with Fragile X syndrome, a genetic disorder caused by an increased number of CGG trinucleotide repeats.\n\n", "output2": "The physical examination findings most likely to be seen in a patient with a learning disability, such as the one described, are those that are associated with the presence of a CGG trinucleotide repeat expansion disorder, such as Fragile X syndrome. Almond-shaped eyes and a downturned mouth are common facial features of this condition.\n\n", "output3": "The physical examination findings most likely to be seen in a patient with a learning disability, such as the one described, are a thin upper lip and receding chin. These features are commonly seen in individuals with Fragile X syndrome, a genetic disorder that is associated with learning disabilities, hyperactivity, and other neurodevelopmental symptoms. The other options (frontal balding and cataracts, long face and large everted ears, almond-shaped eyes and downturned mouth) are not typically associated with Fragile X syndrome.\n\n"}, {"question": "MC location of gastrinoma in MEN-1 syndrome?", "correct_answer": "Duodenum", "correct_idx": 0, "options": ["A)Duodenum", "B)Jejunum", "C)Pancreas", "D)Ileum"], "prompt": "MC location of gastrinoma in MEN-1 syndrome?A)Duodenum\nB)Jejunum\nC)Pancreas\nD)Ileum", "subject_name": "Surgery", "output0": "Gastrinoma is a type of tumor that occurs in the pancreas, and it is associated with MEN-1 syndrome. The tumor is typically located in the duodenum, which is the first part of the small intestine. Therefore, the correct answer is A) Duodenum.\n\n", "output1": "Gastrinoma is a type of neuroendocrine tumor that is often found in the jejunum of individuals with MEN-1 syndrome, a rare genetic disorder. The jejunum is the part of the small intestine between the duodenum and the ileum.\n\n", "output2": "Gastrinoma is a type of neuroendocrine tumor that is often associated with MEN-1 syndrome. These tumors are usually located in the pancreas, specifically in the head of the pancreas. Therefore, the MC location of gastrinoma in MEN-1 syndrome is the pancreas.\n\n", "output3": "Gastrinoma, which is a type of pancreatic neuroendocrine tumor, is often located in the ileum in individuals with MEN-1 syndrome.\n\n"}, {"question": "A 29-year-old, 4 months pregnant primigravida has history of juvenile myoclonic epilepsy. She has been regularly taking sodium valproate and now presents requesting for an opinion for a change in her anti-epileptic treatment. What would you sugeets her?", "correct_answer": "Continue valproate and serial drug monitoring in blood", "correct_idx": 2, "options": ["A)Immediately taper off valproate and sta lamotrigine", "B)Switch to carbamazepine", "C)Continue valproate and serial drug monitoring in blood", "D)Add lamotrigine to valproate"], "prompt": "A 29-year-old, 4 months pregnant primigravida has history of juvenile myoclonic epilepsy. She has been regularly taking sodium valproate and now presents requesting for an opinion for a change in her anti-epileptic treatment. What would you sugeets her?A)Immediately taper off valproate and sta lamotrigine\nB)Switch to carbamazepine\nC)Continue valproate and serial drug monitoring in blood\nD)Add lamotrigine to valproate", "subject_name": "Medicine", "output0": "As the patient is pregnant and has a history of juvenile myoclonic epilepsy, it is recommended to immediately taper off sodium valproate and switch to a different anti-epileptic drug. Lamotrigine is a suitable alternative, but it should be added to valproate gradually to avoid any adverse effects.\n\n", "output1": "Given the patient's history of juvenile myoclonic epilepsy and the fact that she is pregnant, it is recommended to switch to carbamazepine. Sodium valproate is not recommended during pregnancy due to the risk of congenital malformations and developmental disorders. Carbamazepine is a safer alternative for the treatment of epilepsy during pregnancy.\n\n", "output2": "Given the patient's history of juvenile myoclonic epilepsy and current use of sodium valproate, it is important to continue monitoring her seizure control and drug levels regularly. Additionally, the patient is pregnant and should not abruptly stop her medication without proper monitoring, as this could be dangerous for the developing fetus. Therefore, the best option is to continue valproate and serial drug monitoring in blood.\n\n", "output3": "Adding lamotrigine to valproate is a common strategy for managing seizures in patients with juvenile myoclonic epilepsy. This combination has been shown to be effective in reducing seizure frequency and improving outcomes for patients with this condition. Additionally, lamotrigine has a good safety profile and is commonly used in pregnant women with epilepsy.\n\n"}, {"question": "G1cNAc-P-P- oligosacharride is -", "correct_answer": "Glycoprotein", "correct_idx": 1, "options": ["A)Proteoglycan", "B)Glycoprotein", "C)Collagen", "D)Phospholipid"], "prompt": "G1cNAc-P-P- oligosacharride is -A)Proteoglycan\nB)Glycoprotein\nC)Collagen\nD)Phospholipid", "subject_name": "Biochemistry", "output0": "G1cNAc-P-P- oligosacharride is a type of proteoglycan, which is a molecule composed of a protein and a carbohydrate. Proteoglycans are found in the extracellular matrix and play a role in cell signaling, adhesion, and the regulation of inflammation.\n\n", "output1": "G1cNAc-P-P- oligosacharride is a type of glycoprotein, which is a protein that contains carbohydrate chains attached to the protein molecule. In this case, the carbohydrate chains are composed of a series of sugars, including glucose and N-acetylglucosamine.\n\n", "output2": "G1cNAc-P-P- oligosacharride is a type of proteoglycan, which is a protein that is modified by the addition of carbohydrate chains. Collagen is a protein that is rich in carbohydrate chains, and it is a major component of connective tissue. Therefore, G1cNAc-P-P- oligosacharride is a type of collagen.\n\n", "output3": "G1cNAc-P-P- oligosacharride is a type of phospholipid, specifically a glycosylphosphatidylinositol (GPI) anchor. GPI anchors are found in the plasma membrane of many cells and play a role in cell signaling and adhesion.\n\n"}, {"question": "Which of the following modifications in the structure of morphine leads to an increase in analgesic activity ?:", "correct_answer": "Phenethyl group in nitrogen.", "correct_idx": 2, "options": ["A)OH group in position 14 and allyl group in nitrogen.", "B)Cyclopropylmethyl group in nitrogen.", "C)Phenethyl group in nitrogen.", "D)Methoxyl group in place of the phenolic hydroxyl of position 3."], "prompt": "Which of the following modifications in the structure of morphine leads to an increase in analgesic activity ?:A)OH group in position 14 and allyl group in nitrogen.\nB)Cyclopropylmethyl group in nitrogen.\nC)Phenethyl group in nitrogen.\nD)Methoxyl group in place of the phenolic hydroxyl of position 3.", "subject_name": "pharmacology", "output0": "The modification of the morphine structure with the OH group in position 14 and the allyl group in nitrogen increases the analgesic activity of the drug. This is because the OH group in position 14 increases the polarity of the molecule and makes it more soluble in water, while the allyl group in nitrogen increases the bioavailability of the drug.\n\n", "output1": "The cyclopropylmethyl group in nitrogen is a modification that leads to an increase in analgesic activity. This is because it increases the lipophilicity of the molecule, which allows it to more easily cross the blood-brain barrier and bind to opioid receptors in the central nervous system.\n\n", "output2": "The phenethyl group in nitrogen is a common modification of morphine that leads to an increase in analgesic activity. This group increases the affinity of the drug for the opioid receptors, which results in a higher analgesic effect.\n\n", "output3": "The methoxyl group in position 3 of morphine increases its analgesic activity by reducing the metabolism of the drug by the liver. This modification also increases the bioavailability of the drug, leading to a higher and more sustained analgesic effect.\n\n"}]